• OPEN AN ACCOUNT
Indian Indices
Sensex
77,537.72 628.04
( 0.82%)
Global Indices
Nasdaq
53,487.79 123.39
(0.23%)
Dow Jones
7,729.14 16.38
(0.21%)
Hang Seng
66,220.29 893.87
(1.37%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.70 0.10
(0.10%)
EUR-INR
110.78 0.02
(0.01%)
GBP-INR
129.52 -0.04
(-0.03%)
JPY-INR
0.60 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
41.91
1035.75
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

gala global products ltd
Quintegra Solutions reports standalone net loss of Rs 0.05 crore in the June 2026 quarter
Aug 11,2026
Net Loss of Quintegra Solutions reported to Rs 0.05 crore in the quarter ended June 2026 as against net loss of Rs 0.03 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.